Routine employment agreement renewal with no departure, guidance, or financial data — no actionable trading signal. Monitor next 10-Q for any pipeline updates or cash runway changes.
Price Chart
Executive Summary
MediciNova entered into new executive employment agreements with CEO Yuichi Iwaki and CMO Kazuko Matsuda, formalizing base salaries ($690,246 for Iwaki, $540,143 for Matsuda), target bonuses, and severance terms including change-in-control protections. This is a routine compensation and retention filing with no departure, resignation, or financial results — it does not signal any operational or strategic change.
Key Facts
- CEO Yuichi Iwaki's annual base salary set at $690,246 with target bonus of 55% of base salary
- CMO Kazuko Matsuda's annual base salary set at $540,143 with target bonus of 40% of base salary
- Both executives receive 12-month salary severance on involuntary termination without cause (no change in control)
- On change-in-control termination: Iwaki gets 24 months salary + 24 months target bonus; Matsuda gets 18 months salary + 18 months target bonus
- Both executives get 100% accelerated equity vesting on change-in-control termination
- Agreements supersede prior employment and severance arrangements; no departures or resignations reported
Financial Impact
No material financial impact disclosed; incremental severance obligations are standard for a $66M market cap biotech
Risk Factors
- No financial or operational data in filing — limited read-through for equity value
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-356146 |
| Document: 0001193125-26-356146-index-headers.html | 0001193125-26-356146 |
| Document: 0001193125-26-356146-index.html | 0001193125-26-356146 |
| Document: 0001193125-26-356146.txt | 0001193125-26-356146 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | 8-K | $1.43 $1.68 | ▲ +17.48% | ▲ +17.57% | $1.78 (+24.48%) |
Aug 19, 2026 6w ago | 8-K | $1.38 $3.45 | ▲ +150.00% | ▲ +151.95% | $1.78 (+28.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access